Unilever
Trading Statement - Third Quarter 2024
Volume-led growth, positive in all Business Groups
|
|
Third
Quarter 2024
|
Nine
Months 2024
|
(unaudited)
|
USG
|
Turnover
|
vs 2023
|
USG
|
Turnover
|
vs
2023
|
Unilever
|
4.5%
|
€15.2bn
|
-%
|
4.3%
|
€46.4bn
|
1.3%
|
Beauty & Wellbeing
|
6.7%
|
€3.2bn
|
5.5%
|
7.0%
|
€9.8bn
|
5.1%
|
Personal Care
|
4.4%
|
€3.4bn
|
(5.7)%
|
5.2%
|
€10.4bn
|
(1.6)%
|
Home Care
|
1.9%
|
€3.0bn
|
(2.9)%
|
2.8%
|
€9.3bn
|
-%
|
Nutrition
|
1.5%
|
€3.2bn
|
(1.5)%
|
2.6%
|
€9.9bn
|
0.3%
|
Ice Cream
|
9.8%
|
€2.4bn
|
8.1%
|
3.6%
|
€7.0bn
|
3.9%
|
Third quarter highlights
• Underlying sales growth (USG)
of 4.5%, with volume growth increasing to 3.6%
• Power Brands
(>75% of turnover) leading growth with
5.4% USG and volumes up
4.3%
• Turnover of €15.2
billion with (2.8)% impact from
currency and (1.5)% from net disposals
• 2024 full year outlook
unchanged with 3-5% USG and an
underlying operating margin of at least 18%
• Final tranche underway of 2024
share buyback programme of up to €1.5 billion
• Productivity programme and
separation of Ice Cream on track
Chief Executive Officer
statement
"We have delivered a fourth
consecutive quarter of positive, improved volume growth, with each
of our Business Groups driving higher volumes
year-on-year.
Underlying sales grew 4.5%, led by
our Power Brands, with particularly strong performances from Dove,
Liquid I.V., Comfort and Magnum. Price growth continued to moderate
in line with our expectations.
We are still in the early stages of
transforming our performance as we execute the Growth Action Plan
at pace - focused on doing fewer things, better and with greater
impact. We are starting to see the positive impact from scaling
fewer, bigger innovations across our markets supported by increased
brand investment. We are taking decisive actions, where we see
operational or market challenges to ensure we are well positioned
for consistent and improved performance. As part of the Group's
overall transformation, we are implementing a comprehensive
productivity programme and the separation of Ice Cream, both of
which are progressing as planned.
We are on track to deliver our 2024
outlook and are confident that the steps we are taking will help to
transform Unilever over time into a consistently higher performing
business."
Hein Schumacher
Our full year 2024 outlook is
unchanged.
We continue to expect underlying
sales growth (USG) for 2024 to be within our multi-year range of 3%
to 5%, with the majority of the growth being driven by
volume.
Underlying operating margin for the
full year is expected to be at least 18%, with increasing
investment behind our brands. We expect the year-on-year margin
progression in the second half to be smaller than in the first
half.
Third
Quarter Review: Unilever Group
|
Growth
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Acquisitions
|
Disposals
|
Currency
|
Turnover
change
|
Third Quarter
|
€15.2bn
|
4.5%
|
3.6%
|
0.9%
|
0.3%
|
(1.8)%
|
(2.8)%
|
-%
|
Nine Months
|
€46.4bn
|
4.3%
|
2.9%
|
1.3%
|
0.4%
|
(1.4)%
|
(1.9)%
|
1.3%
|
Underlying sales growth in the third
quarter was 4.5%, against the backdrop of slower market growth.
Underlying volume growth (UVG) increased to 3.6% in Q3, the fourth
consecutive quarter of positive and improving volume growth. All
business groups achieved positive volume growth. As expected,
underlying price growth continued to moderate to 0.9% in
Q3.
The Power Brands performed strongly
with 5.4% underlying sales growth, driven by volume growth of 4.3%.
Our other brands also delivered volume growth of 1.3% in Q3, up
from (1.6)% in H1.
Beauty & Wellbeing grew
underlying sales 6.7%, with volume growth of 5.7%. Health &
Wellbeing and Prestige Beauty combined delivered a fifteenth
consecutive quarter of double-digit, volume-led growth. Strong
growth in Health & Wellbeing more than offset softer growth in
Prestige, reflecting the continued slowdown in the US and China
beauty markets. Personal Care grew 4.4% with 3.1% from volume,
driven by a strong Dove
performance. Home Care underlying sales increased by 1.9%, with
3.3% volume growth more than offsetting continued negative price
growth linked to commodity cost deflation. Nutrition grew
underlying sales 1.5%, with muted volume growth of 0.4% amidst
moderating prices and market slowdown. Ice Cream grew 9.8%, with
6.7% from volume and 2.9% from price. This improved performance
reflects the continued focus on operational improvements alongside
strong innovations, amplified by a weak comparator.
Developed markets (43% of Group
turnover) grew underlying sales 6.9% with 6.8% from volume and 0.1%
from price. Volume growth was broad-based and reflected strong
growth in Beauty & Wellbeing in North America, strong growth in
Home Care in Europe and a marked volume improvement in Ice Cream.
As expected, price growth moderated further.
Emerging markets (57% of Group
turnover) grew underlying sales 2.9%, with 1.4% from volume and
1.5% from price. India grew 2.3% with volume growth of 3.4%.
Underlying price growth of (1.0)% in India lapped a one-off
indirect tax benefit in the prior year, without which Q3 UPG would
have been flat. Latin America grew 3.8%. This slower rate of growth
reflected a decline in the laundry powders market in Brazil and
low-single digit growth in Mexico after eight quarters of
double-digit growth. Africa and Turkey continued to deliver
double-digit growth.
China declined low-single digit with
market weakness across categories and in the context of softer
markets, we are transforming our go-to-market approach. South East
Asia declined mid-single digit, driven by an (18)% decline in
Indonesia which was only partially offset by volume-led growth in
Philippines and Thailand.
We are making decisive interventions
to fix our long-standing issues in Indonesia, which include
removing price instability across channels and resetting stock
levels in retail to what we consider optimum levels. We expect to
see the benefits of the changes in Indonesia and China from the
second half of 2025.
Turnover of €15.2 billion was in
line with the prior year, as underlying sales growth was offset by
a currency impact of (2.8)% and (1.5)% from disposals net of
acquisitions.
Progress on Ice Cream separation and
productivity programme
In March, we announced the
separation of Ice Cream and the launch of a major productivity
programme to strengthen the company and substantially improve our
efficiency and effectiveness.
Separation activity is on track to
complete by the end of 2025. We are progressing with the legal
entity set up, the standalone operating model and the carve-out
financials.
In July, we communicated internally
on the changes planned within the productivity programme to
simplify our business and further evolve our category-focused
operating model. We have started the implementation in those
countries where the consultation with the respective works councils
completed.
Capital allocation
On 2 August 2024, we completed the
sale of our stake in Qinyuan Group (also known as "Truliva"), which
offers a range of water purification solutions to households in
China, to Yong Chao Venture Capital Co., Ltd.
On 10 October 2024, we completed the
sale of our Russian subsidiary to Arnest Group. The sale includes
all of Unilever's business in Russia and its four factories, as
well as our business in Belarus.
In February 2024, we announced a
share buyback programme of up to €1.5 billion to be conducted
during 2024. The first tranche of €700 million completed in August.
The second tranche of up to €800 million commenced in September and
will complete in December 2024.
After the quarterly interim dividend
for the second quarter was raised by 3.0% to €0.4396, the quarterly
interim dividend for the third quarter is maintained at this
level.
Following the release of this
trading statement on 24 October 2024 at 7:00 AM (UK time),
there will be a live webcast at 8:00 AM available
on the website
www.unilever.com/investor-relations/results-and-presentations/latest-results.
A replay of the webcast and the
slides of the presentation will be made available after the live
meeting.
Date
|
Events
|
22 November 2024
|
Unilever Investor Event
2024
|
13 February 2025
|
Q4 and FY 2024 results
|
Third
Quarter Review: Business Groups
|
|
Third Quarter 2024
|
Nine
Months 2024
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Turnover
|
USG
|
UVG
|
UPG
|
Unilever
|
€15.2bn
|
4.5%
|
3.6%
|
0.9%
|
€46.4bn
|
4.3%
|
2.9%
|
1.3%
|
Beauty & Wellbeing
|
€3.2bn
|
6.7%
|
5.7%
|
0.9%
|
€9.8bn
|
7.0%
|
5.6%
|
1.3%
|
Personal Care
|
€3.4bn
|
4.4%
|
3.1%
|
1.3%
|
€10.4bn
|
5.2%
|
3.0%
|
2.2%
|
Home Care
|
€3.0bn
|
1.9%
|
3.3%
|
(1.4)%
|
€9.3bn
|
2.8%
|
4.2%
|
(1.3)%
|
Nutrition
|
€3.2bn
|
1.5%
|
0.4%
|
1.1%
|
€9.9bn
|
2.6%
|
0.1%
|
2.5%
|
Ice Cream
|
€2.4bn
|
9.8%
|
6.7%
|
2.9%
|
€7.0bn
|
3.6%
|
1.5%
|
2.1%
|
Beauty & Wellbeing
(21% of Q3 turnover)
In
Beauty & Wellbeing, we focus on three key priorities that will
drive the unmissable superiority of our brands: elevating our core
Hair Care and Skin Care brands to increase premiumisation; fuelling
the growth of Prestige Beauty and Health & Wellbeing with
selective international expansion; and continuing to strengthen our
beauty and wellbeing capabilities.
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Acquisitions
|
Disposals
|
Currency
|
Turnover
change
|
Third Quarter
|
€3.2bn
|
6.7%
|
5.7%
|
0.9%
|
1.0%
|
-%
|
(2.1)%
|
5.5%
|
Nine Months
|
€9.8bn
|
7.0%
|
5.6%
|
1.3%
|
0.9%
|
(1.1)%
|
(1.6)%
|
5.1%
|
Beauty & Wellbeing delivered a
strong performance, with underlying sales up 6.7%, driven by volume
up 5.7% and price up 0.9%.
Hair Care delivered low-single digit
growth with low-single digit volume growth. Dove continued to deliver volume-led
growth following the first half launch of Scalp + Hair Therapy,
while TRESemmé grew
mid-single digit with continued success of its treatments and
styling range. Our largest hair care brand, Sunsilk, grew low-single digit and
Clear achieved high-single
digit growth outside China, but was flat overall.
Core Skin Care grew mid-single digit
led by double-digit volume growth in the United States.
Dove achieved strong
double-digit growth, which included the launch of High Potency Body
Serums and 3-in-1 face care treatments in Brazil. Pond's grew double-digit supported by
our Bright Miracle and Age Miracle face care ranges, featuring
advanced technologies for clearer, more youthful skin. Vaseline continued to perform well,
supported by the continued rollout of premium innovations like
Radiant X and Gluta Hya, as well as the launch of Pro VitaB3
Serum-Burst Lotion in the United States.
Health & Wellbeing and Prestige
Beauty combined delivered double-digit growth for the fifteenth
consecutive quarter. This was led by very strong growth in Health
& Wellbeing, which offset lower growth in Prestige Beauty
reflecting the continued slowdown in the United States and China
beauty markets. Liquid I.V.
delivered another quarter of strong double-digit growth, driven by
a successful summer season and continued international expansion.
Nutrafol and Olly also saw strong double-digit
growth, with Olly's female
health supplements performing well in China. Hourglass led Prestige growth with
strong double-digit growth, driven by hero products such as Vanish
Airbrush Concealer and Veil Hydrating Skin Tint, while Paula's Choice was impacted by the
market slowdown.
Personal Care (22% of Q3 turnover)
In
Personal Care, we focus on winning with science-led brands that
deliver unmissable superiority to our consumers across Deodorants,
Skin Cleansing, and Oral Care. Our priorities include developing
superior technology and multi-year innovation platforms, leveraging
partnerships with our customers, and expanding into premium areas
and digital channels.
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Acquisitions
|
Disposals
|
Currency
|
Turnover
change
|
Third Quarter
|
€3.4bn
|
4.4%
|
3.1%
|
1.3%
|
-%
|
(6.3)%
|
(3.6)%
|
(5.7)%
|
Nine Months
|
€10.4bn
|
5.2%
|
3.0%
|
2.2%
|
-%
|
(4.4)%
|
(2.1)%
|
(1.6)%
|
Personal Care delivered volume-led
growth with underlying sales up 4.4%, driven by volume up 3.1% and
price up 1.3%.
Deodorants grew high-single digit,
which was volume-led. Latin America led growth with double-digit
volume, while Europe and North America saw mid-single digit
increases. Dove continued
to grow double-digit with strength across both core women and
Dove Men+Care ranges,
including our expansion into the whole body deodorants market in
the first half. Axe and
Rexona continued to grow,
driven by the ongoing success of our fine fragrance and clinical
ranges.
Skin Cleansing grew low-single digit
fully driven by volume. In Europe, we achieved high-single digit
growth driven by volume increases, while in the United States, we
saw mid-single digit growth. Dove delivered high-single digit
growth, supported by the first-half relaunch of Dove's body wash in Europe and the
launch of Dove's premium
body wash range infused with skincare serums in the United States.
Growth was tempered by deflation in India, category declines in
China, and operational challenges in Indonesia.
Oral Care grew low-single digit with
mid-single digit growth in Europe partially offset by a decline in
Indonesia.
Home Care (20% of Q3 turnover)
In
Home Care, we focus on delivering for consumers who want superior
products that are sustainable and great value. We drive growth
through unmissable superiority in our biggest brands, in our key
markets and across channels. We have a resilient business that
spans price points and grows the market by premiumising and trading
consumers up to additional benefits.
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Acquisitions
|
Disposals
|
Currency
|
Turnover
change
|
Third Quarter
|
€3.0bn
|
1.9%
|
3.3%
|
(1.4)%
|
-%
|
(1.2)%
|
(3.6)%
|
(2.9)%
|
Nine Months
|
€9.3bn
|
2.8%
|
4.2%
|
(1.3)%
|
-%
|
(0.4)%
|
(2.3)%
|
-%
|
Home Care underlying sales grew
1.9%, with volume growth of 3.3%, partially offset by a (1.4)%
price decline.
Fabric Cleaning declined low-single
digit as slightly positive volume was more than offset by
low-single digit negative price. Europe led with high-single digit
growth, driven by double-digit volume. Persil Wonder Wash, featuring our
patented Pro-S technology designed for short cycle washes,
continued to perform well and was launched in Turkey in Q3. In
India, we grew high-single digit driven by strong volumes and
double-digit growth in liquids led by our Surf Excel Matic and Rin ranges. Brazil saw declines in both
price and volume due to a softening market and commodity deflation,
particularly affecting our powders portfolio.
Home & Hygiene grew mid-single
digit led by volume. Domestos grew double-digit led by
momentum in our Power Foam range which expanded to new geographies
including Poland and Turkey. Cif also maintained double-digit,
volume-led growth.
Fabric Enhancers grew double-digit
with strong volumes slightly offset by negative price. Comfort continued to deliver
double-digit volume growth following the successful first-half
launch of our new, Botanicals and Elixir ranges, with our patented
CrystalFresh technology.
Nutrition (21% of Q3 turnover)
In
Nutrition, our strategy is to deliver consistent, competitive
growth by offering unmissably superior products through our biggest
brands. We do this by reaching more consumers and focusing on top
dishes and high consumption seasons to satisfy consumer's
preferences on taste, health and sustainability; while delivering
productivity and resilience in our supply chain.
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Acquisitions
|
Disposals
|
Currency
|
Turnover
change
|
Third Quarter
|
€3.2bn
|
1.5%
|
0.4%
|
1.1%
|
-%
|
(0.5)%
|
(2.5)%
|
(1.5)%
|
Nine Months
|
€9.9bn
|
2.6%
|
0.1%
|
2.5%
|
-%
|
(0.4)%
|
(1.9)%
|
0.3%
|
Nutrition underlying sales grew
1.5%, driven by positive price and volume.
Scratch Cooking Aids grew low-single
digit, led by mid-single digit growth in Knorr. In Latin America, we achieved
double-digit growth, driven by strong performance from our next
generation bouillon & seasoning ranges with enhanced flavours
and micronutrients. In the United States, we saw mid-single digit
growth, entirely volume-driven, benefiting from social-first
campaigns promoting home cooking with bouillon.
Dressings was flat with low-single
digit volume offset by negative price. Hellmann's delivered low-single digit
volume growth which was offset by negative price as promotional
intensity increased. Flavoured mayo continued to perform well with
rapid geographic expansion, including recent launches in Argentina
and the Philippines.
Unilever Food Solutions grew
low-single digit with positive volumes despite a slowdown in China.
We continued to expand our digital selling programme and benefited
from the launch of Hellmann's Professional Mayo in Europe
and Brazil, specifically designed for professional
kitchens.
Ice Cream (16% of Q3 turnover)
In
Ice Cream, our immediate strategic priority is to expand operating
profit and global market share. We will do this by building the
unmissable superiority of our brands, accelerating market
development in emerging markets, continuing to lead the industry on
innovation and premiumisation, and by stepping up our performance
and productivity. In March, we announced the planned separation of
Ice Cream which we expect to be completed by the end of 2025. The
separation will create a world-leading business, operating in a
highly attractive category with five of the top 10 selling global
ice cream brands.
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Acquisitions
|
Disposals
|
Currency
|
Turnover
change
|
Third Quarter
|
€2.4bn
|
9.8%
|
6.7%
|
2.9%
|
0.7%
|
-%
|
(2.3)%
|
8.1%
|
Nine Months
|
€7.0bn
|
3.6%
|
1.5%
|
2.1%
|
1.5%
|
-%
|
(1.2)%
|
3.9%
|
Ice Cream underlying sales grew
9.8%, with 6.7% from volume and 2.9% from price. This improved
performance was driven by operational strengthening, including
distribution gains and optimised promotional activities, alongside
strong innovations. These improvements were amplified by a weak Q3
2023 comparator.
In-home grew double-digit led by
double-digit volume growth in Europe. Magnum's first bite-sized innovation,
Bon Bons, along with Ben &
Jerry's Peaces and Yasso's Poppables, performed well.
These premium micro-format innovations cater to the demand for
smaller, frequent indulgences, driving growth in the Ice Cream
category year-round.
Out-of-home grew high-single digit
with positive volume and price growth. Magnum achieved double-digit growth,
with continued strong performance of its premium 'Pleasure Express'
range, featuring Euphoria, Wonder, and Chill. Ben & Jerry's and Cornetto saw high-single digit growth,
supported by Cornetto's
first global relaunch with enhanced formulation and new
packaging.
Third
Quarter Review: Geographical Areas
|
|
Third Quarter 2024
|
Nine
Months 2024
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Turnover
|
USG
|
UVG
|
UPG
|
Unilever
|
€15.2bn
|
4.5%
|
3.6%
|
0.9%
|
€46.4bn
|
4.3%
|
2.9%
|
1.3%
|
Asia Pacific Africa
|
€6.5bn
|
2.5%
|
1.0%
|
1.5%
|
€19.9bn
|
3.2%
|
2.0%
|
1.2%
|
The Americas
|
€5.5bn
|
5.9%
|
4.6%
|
1.3%
|
€16.9bn
|
5.6%
|
4.1%
|
1.4%
|
Europe
|
€3.2bn
|
6.5%
|
7.7%
|
(1.0)%
|
€9.6bn
|
4.5%
|
2.9%
|
1.5%
|
|
Third Quarter 2024
|
Nine
Months 2024
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Turnover
|
USG
|
UVG
|
UPG
|
Emerging markets
|
€8.7bn
|
2.9%
|
1.4%
|
1.5%
|
€27.0bn
|
4.4%
|
3.0%
|
1.3%
|
Developed markets
|
€6.5bn
|
6.9%
|
6.8%
|
0.1%
|
€19.4bn
|
4.1%
|
2.8%
|
1.3%
|
North America
|
€3.3bn
|
7.4%
|
6.2%
|
1.1%
|
€10.0bn
|
4.7%
|
3.4%
|
1.3%
|
Latin America
|
€2.2bn
|
3.8%
|
2.0%
|
1.7%
|
€6.9bn
|
7.0%
|
5.3%
|
1.6%
|
Asia Pacific Africa
(43% of Q3 turnover)
Underlying sales growth was 2.5%
with 1.0% from volume and 1.5% from price.
India grew 2.3% driven by volume at
3.4%. Price at (1.0)% lapped an indirect tax one-off in the 2023
base; excluding this, Q3 UPG would have been flat. Growth was led
by strong volume in both Beauty & Wellbeing and Home Care.
Africa and Turkey continued to grow double-digit with positive
price and volume.
China declined low-single digit
amidst continued weak consumer sentiment. In addition, we are
resetting our go-to-market approach with higher category focus,
updated channel strategies and sharper geographic choices. We
appointed new leadership in China, and we will continue to build on
our strong positions in core categories.
Underlying sales declined (18)% in
Indonesia, primarily due to our long-standing operational
issues.
We are taking significant actions in
Indonesia, which include removing price instability across channels
and resetting stock levels in retail to what we consider optimum
levels.
We expect to see the benefits of the
changes in Indonesia and China from the second half of
2025.
The Americas (36% of Q3 turnover)
Underlying sales grew 7.4% in North
America with 6.2% from volume and 1.1% from price. Beauty &
Wellbeing delivered double-digit, volume-led growth, driven by a
strong performance in Health & Wellbeing and continued good
momentum in Vaseline.
Personal Care saw a balanced mid-single digit growth, supported by
Dove. Nutrition grew
low-single digit with positive volume and price, but reflecting a
slowdown in category growth. Ice Cream contributed high-single
digit volume growth and positive price supported by strong
Popsicle SpongeBob and
Minions innovations.
Underlying sales in Latin America
decelerated to 3.8% with 2.0% volume and 1.7% price. Beauty &
Wellbeing and Personal Care grew high-single digit with positive
price and volume, led by double-digit volume growth in Deodorants
and Skin Care. Home Care declined low-single digit, adversely
affected by a slowdown in Brazil powders' market. Nutrition grew
mid-single digit with a strong performance from Knorr. Ice Cream declined low-single
digit driven by adverse weather conditions in the region. Brazil
grew low-single digit with strong growth from Beauty &
Wellbeing and Personal Care. Mexico experienced low-single digit
growth as pricing and volumes began to normalise after double-digit
growth over the previous eight quarters. Despite ongoing economic
adjustments in Argentina and continued hyperinflationary pricing,
we delivered positive volume growth.
Europe (21%
of Q3 turnover)
Underlying sales grew 6.5% with
volume growth of 7.7% partially offset by negative price of (1.0)%.
Our stepped-up performance in Europe was underpinned by a strong
innovation programme and increased levels of brand investment. Ice
Cream and Home Care delivered double-digit, volume-led growth,
while Personal Care grew mid-single digit, led by another quarter
of strong volume growth in Deodorants. Nutrition was slightly
positive. Growth was broad-based in Europe, with all major markets
delivering positive volume growth in the quarter.
The Board has declared a quarterly
interim dividend for Q3 2024 of £0.3663 per Unilever PLC ordinary
share or €0.4396 per Unilever PLC ordinary share at the applicable
exchange rate issued by WM/Reuters on 22 October 2024.
The following amounts will be paid
in respect of this quarterly interim dividend on the relevant
payment date:
Per Unilever PLC ordinary share
(traded on the London Stock Exchange):
|
£0.3663
|
Per Unilever PLC ordinary share
(traded on Euronext in Amsterdam):
|
€0.4396
|
Per Unilever PLC American Depositary
Receipt:
|
US$0.4755
|
The euro and US dollar amounts above
have been determined using the applicable exchange rates issued by
WM/Reuters on 22 October 2024.
US dollar cheques for the quarterly
interim dividend will be mailed on 06 December 2024 to holders
of record at the close of business on 08 November
2024.
The quarterly dividend calendar for
the remainder of 2024 will be as follows:
|
Announcement Date
|
Ex-dividend Date for Ordinary Shares
|
Ex-dividend Date for ADRs
|
Record
Date
|
Payment
Date
|
Q3 2024
Dividend
|
24
October 2024
|
07
November 2024
|
08
November 2024
|
08
November 2024
|
06
December 2024
|
Segment
Information - Business Groups
|
(unaudited)
|
|
|
|
|
|
|
Third Quarter
|
Beauty
& Wellbeing
|
Personal
Care
|
Home
Care
|
Nutrition
|
Ice
Cream
|
Total
|
Turnover (€ million)
|
|
|
|
|
|
|
2023
|
3,106
|
3,597
|
3,084
|
3,250
|
2,205
|
15,242
|
2024
|
3,276
|
3,393
|
2,993
|
3,201
|
2,383
|
15,246
|
Change (%)
|
5.5
|
(5.7)
|
(2.9)
|
(1.5)
|
8.1
|
-
|
Impact of:
|
|
|
|
|
|
|
Acquisitions (%)
|
1.0
|
-
|
-
|
-
|
0.7
|
0.3
|
Disposals (%)
|
-
|
(6.3)
|
(1.2)
|
(0.5)
|
-
|
(1.8)
|
Currency-related items (%), of
which:
|
(2.1)
|
(3.6)
|
(3.6)
|
(2.5)
|
(2.3)
|
(2.8)
|
Exchange rates changes (%)
|
(3.7)
|
(5.3)
|
(6.6)
|
(4.4)
|
(4.4)
|
(4.9)
|
Extreme price growth in hyperinflationary
markets*
|
1.7
|
1.8
|
3.2
|
2.0
|
2.2
|
2.2
|
Underlying sales growth
(%)
|
6.7
|
4.4
|
1.9
|
1.5
|
9.8
|
4.5
|
Price* (%)
|
0.9
|
1.3
|
(1.4)
|
1.1
|
2.9
|
0.9
|
Volume (%)
|
5.7
|
3.1
|
3.3
|
0.4
|
6.7
|
3.6
|
Nine Months
|
Beauty
& Wellbeing
|
Personal
Care
|
Home
Care
|
Nutrition
|
Ice
Cream
|
Total
|
Turnover (€ million)
|
|
|
|
|
|
|
2023
|
9,343
|
10,515
|
9,325
|
9,861
|
6,733
|
45,777
|
2024
|
9,817
|
10,349
|
9,326
|
9,890
|
6,996
|
46,378
|
Change (%)
|
5.1
|
(1.6)
|
-
|
0.3
|
3.9
|
1.3
|
Impact of:
|
|
|
|
|
|
|
Acquisitions (%)
|
0.9
|
-
|
-
|
-
|
1.5
|
0.4
|
Disposals (%)
|
(1.1)
|
(4.4)
|
(0.4)
|
(0.4)
|
-
|
(1.4)
|
Currency-related items (%), of
which:
|
(1.6)
|
(2.1)
|
(2.3)
|
(1.9)
|
(1.2)
|
(1.9)
|
Exchange rates changes (%)
|
(3.2)
|
(3.9)
|
(5.5)
|
(3.6)
|
(3.2)
|
(3.9)
|
Extreme price growth in hyperinflationary
markets*
|
1.6
|
1.9
|
3.3
|
1.8
|
2.1
|
2.1
|
Underlying sales growth
(%)
|
7.0
|
5.2
|
2.8
|
2.6
|
3.6
|
4.3
|
Price* (%)
|
1.3
|
2.2
|
(1.3)
|
2.5
|
2.1
|
1.3
|
Volume (%)
|
5.6
|
3.0
|
4.2
|
0.1
|
1.5
|
2.9
|
* Underlying price growth in excess
of 26% per year in hyperinflationary economies has been excluded
when calculating the price growth in the tables above, and an equal
and opposite amount is shown as extreme price growth in
hyperinflationary markets.
Turnover growth is made up of
distinct individual growth components namely underlying sales,
currency impact, acquisitions and disposals. Turnover growth is
arrived at by multiplying these individual components on a
compounded basis as there is a currency impact on each of the other
components. Accordingly, turnover growth is more than just the sum
of the individual components.
Segment
Information - Geographical Areas
|
(unaudited)
|
|
|
|
|
Third Quarter
|
Asia
Pacific Africa
|
The
Americas
|
Europe
|
Total
|
Turnover (€ million)
|
|
|
|
|
2023
|
6,600
|
5,525
|
3,117
|
15,242
|
2024
|
6,493
|
5,478
|
3,275
|
15,246
|
Change (%)
|
(1.6)
|
(0.9)
|
5.1
|
-
|
Impact of:
|
|
|
|
|
Acquisitions (%)
|
-
|
0.9
|
-
|
0.3
|
Disposals (%)
|
(0.9)
|
(3.1)
|
(1.8)
|
(1.8)
|
Currency-related items (%), of
which:
|
(3.2)
|
(4.3)
|
0.4
|
(2.8)
|
Exchange rates changes (%)
|
(4.7)
|
(8.1)
|
0.4
|
(4.9)
|
Extreme price growth in hyperinflationary
markets*
|
1.6
|
4.2
|
-
|
2.2
|
Underlying sales growth
(%)
|
2.5
|
5.9
|
6.5
|
4.5
|
Price* (%)
|
1.5
|
1.3
|
(1.0)
|
0.9
|
Volume (%)
|
1.0
|
4.6
|
7.7
|
3.6
|
Nine Months
|
Asia
Pacific Africa
|
The
Americas
|
Europe
|
Total
|
Turnover (€ million)
|
|
|
|
|
2023
|
20,141
|
16,467
|
9,169
|
45,777
|
2024
|
19,869
|
16,950
|
9,559
|
46,378
|
Change (%)
|
(1.3)
|
2.9
|
4.3
|
1.3
|
Impact of:
|
|
|
|
|
Acquisitions (%)
|
-
|
1.1
|
-
|
0.4
|
Disposals (%)
|
(0.5)
|
(2.9)
|
(0.8)
|
(1.4)
|
Currency-related items (%), of
which:
|
(3.9)
|
(0.7)
|
0.6
|
(1.9)
|
Exchange rates changes (%)
|
(5.4)
|
(4.6)
|
0.6
|
(3.9)
|
Extreme price growth in hyperinflationary
markets*
|
1.5
|
4.1
|
-
|
2.1
|
Underlying sales growth
(%)
|
3.2
|
5.6
|
4.5
|
4.3
|
Price* (%)
|
1.2
|
1.4
|
1.5
|
1.3
|
Volume (%)
|
2.0
|
4.1
|
2.9
|
2.9
|
* Underlying price growth in excess
of 26% per year in hyperinflationary economies has been excluded
when calculating the price growth in the tables above, and an equal
and opposite amount is shown as extreme price growth in
hyperinflationary markets.
In our financial reporting we use
certain measures that are not defined by generally accepted
accounting principles (GAAP) such as IFRS. We believe this
information, along with comparable GAAP measurements, is useful to
investors because it provides a basis for measuring our operating
performance, and our ability to retire debt and invest in new
business opportunities. Our management uses these financial
measures, along with the most directly comparable GAAP financial
measures, in evaluating our operating performance and value
creation. Non-GAAP financial measures should not be considered in
isolation from, or as a substitute for, financial information
presented in compliance with GAAP. Wherever appropriate and
practical, we provide reconciliations to relevant GAAP measures.
The non-GAAP measures used in this announcement are underlying
sales growth, underlying volume growth and underlying price growth
(see below).
Underlying sales growth
(USG)
Underlying sales growth (USG) refers
to the increase in turnover for the period, excluding any change in
turnover resulting from acquisitions, disposals, changes in
currency and price growth in excess of 26% in hyperinflationary
economies. Inflation of 26% per year compounded over three years is
one of the key indicators within IAS 29 to assess whether an
economy is deemed to be hyperinflationary. We believe this measure
provides valuable additional information on the underlying sales
performance of the business and is a key measure used internally.
The impact of acquisitions and disposals is excluded from USG for a
period of 12 calendar months from the applicable closing date.
Turnover from acquired brands that are launched in countries where
they were not previously sold is included in USG as such turnover
is more attributable to our existing sales and distribution network
than the acquisition itself. The reconciliation of changes in the
GAAP measure turnover to USG is provided on page
9 and 10.
Underlying price growth
(UPG)
Underlying price growth (UPG) is
part of USG and means, for the applicable period, the increase in
turnover attributable to changes in prices during the period. UPG
therefore excludes the impact to USG due to (i) the volume of
products sold; and (ii) the composition of products sold during the
period. In determining changes in price we exclude the impact of
price growth in excess of 26% per year in hyperinflationary
economies as explained in USG above. The measures and the related
turnover GAAP measure are set out on page 9 and 10.
Underlying volume growth
(UVG)
Underlying volume growth (UVG) is
part of USG and means, for the applicable period, the increase in
turnover in such period calculated as the sum of (i) the increase
in turnover attributable to the volume of products sold; and (ii)
the increase in turnover attributable to the composition of
products sold during such period. UVG therefore excludes any impact
on USG due to changes in prices. The measures and the related
turnover GAAP measure are set out on page 9 and 10.
This announcement may contain
forward-looking statements, including 'forward-looking statements'
within the meaning of the United States Private Securities
Litigation Reform Act of 1995, concerning the financial condition,
results of operations and businesses of the Unilever Group (the
'Group'). All statements other than statements of historical fact
are, or may be deemed to be, forward-looking statements. Words and
terminology such as 'will', 'aim', 'expects', 'anticipates',
'intends', 'looks', 'believes', 'vision', 'ambition', 'target',
'goal', 'plan', 'potential', 'work towards', 'may', 'milestone',
'objectives', 'outlook', 'probably', 'project', 'risk', 'seek',
'continue', 'projected', 'estimate', 'achieve' or the negative of
these terms, and other similar expressions of future performance,
results, actions or events, and their negatives, are intended to
identify such forward-looking statements. Forward-looking
statements also include, but are not limited to, statements and
information regarding Unilever's acceleration of its Growth Action
Plan, Unilever's portfolio optimisation towards global or scalable
brands, the capabilities and potential of such brands, the various
aspects of the separation of Ice Cream and its future operational
model, strategy, growth potential, performance and returns,
Unilever's productivity programme, its impacts and cost savings
over the next three years and operation dis-synergies from the
separation of Ice Cream, the Group's emissions reduction targets
and other climate change related matters (including actions,
potential impacts and risks associated therewith). Forward-looking
statements can be made in writing but also may be made verbally by
directors, officers and employees of the Group (including during
management presentations) in connection with this announcement.
These forward-looking statements are based upon current beliefs,
expectations and assumptions regarding anticipated developments and
other factors affecting the Group. They are not historical facts,
nor are they guarantees of future performance or outcomes. All
forward-looking statements contained in this announcement are
expressly qualified in their entirety by the cautionary statements
contained or referred to in this section. Readers should not place
undue reliance on forward-looking statements.
Because these forward-looking
statements involve known and unknown risks and uncertainties, a
number of which may be beyond the Group's control, there are
important factors that could cause actual results to differ
materially from those expressed or implied by these forward-looking
statements. Among other risks and uncertainties, the material or
principal factors which could cause actual results to differ
materially from the forward-looking statements expressed in this
announcement are: Unilever's ability to successfully separate Ice
Cream and realise the anticipated benefits of the separation;
Unilever's ability to successfully execute and consummate its
productivity programme in line with expected costs to achieve
expected savings; Unilever's global brands not meeting consumer
preferences; Unilever's ability to innovate and remain competitive;
Unilever's investment choices in its portfolio management; the
effect of climate change on Unilever's business; Unilever's ability
to find sustainable solutions to its plastic packaging; significant
changes or deterioration in customer relationships; the recruitment
and retention of talented employees; disruptions in Unilever's
supply chain and distribution; increases or volatility in the cost
of raw materials and commodities; the production of safe and high
quality products; secure and reliable IT infrastructure; execution
of acquisitions, divestitures and business transformation projects;
economic, social and political risks and natural disasters;
financial risks; failure to meet high and ethical standards; and
managing regulatory, tax and legal matters.
The forward-looking statements speak
only as of the date of this announcement. Except as required by any
applicable law or regulation, the Group expressly disclaims any
intention, obligation or undertaking to release publicly any
updates or revisions to any forward-looking statements contained
herein to reflect any change in the Group's expectations with
regard thereto or any change in events, conditions or circumstances
on which any such statement is based. New risks and uncertainties
arise over time, and it is not possible for us to predict those
events or how they may affect us. In addition, we cannot assess the
impact of each factor on our business or the extent to which any
factor, or combination of factors, may cause actual results to
differ materially from those contained in any forward-looking
statements.
Further details of potential risks
and uncertainties affecting the Group are described in the Group's
filings with the London Stock Exchange, Euronext Amsterdam and the
US Securities and Exchange Commission, including in the Annual
Report on Form 20-F 2023 and the Unilever Annual Report and
Accounts 2023.
Media: Media
Relations Team
|
Investors: Investor Relations Team
|
UK
|
+44 78 2527 3767
|
lucila.zambrano@unilever.com
|
investor.relations@unilever.com
|
or
|
+44 77 7999 9683
|
jonathan.sibun@teneo.com
|
|
NL
|
+31 62 191 3705
|
kiran.hofker@unilever.com
|
|
or
|
+31 61 500 8293
|
fleur-van.bruggen@unilever.com
|
|
After the conference call on 24
October 2024 at 8:00 AM (UK time), the webcast of the presentation
will be available at:
www.unilever.com/investor-relations/results-and-presentations/latest-results.
This Results Presentation has been
submitted to the FCA National Storage Mechanism and is available
for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.